A comparative quantitative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis

Rheumatology

Volumn 38, Issue 5, 1999, Pages 431-440

  Ceponis A ^a,e   Hietanen, J ^a   Tamulaitiene, M ^b   Partsch, G ^c   Patiala H ^d   Konttinen, Y T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Inst of Exp and Clinical Medicine   (Lithuania)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e ORTON Invalid Foundation   (Finland)

Author keywords

Apoptosis; Psoriatic arthritis; Reactive arthritis; Rheumatoid arthritis; Synovial membrane

Indexed keywords

ALLOPURINOL; ANTIINFECTIVE AGENT; CD68 ANTIGEN; CELL MARKER; CHLOROQUINE; DNA; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL HYPERPLASIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA STRAND BREAKAGE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IMMUNOPEROXIDASE STAINING; INFLAMMATORY CELL; MALE; MORPHOMETRICS; PHENOTYPE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM;

ADULT; APOPTOSIS; ARTHRITIS; ARTHRITIS, PSORIATIC; ARTHRITIS, REACTIVE; ARTHRITIS, RHEUMATOID; ELBOW JOINT; FEMALE; HIP JOINT; HUMANS; IN SITU NICK-END LABELING; KNEE JOINT; MALE; MIDDLE AGED; STROMAL CELLS; SYNOVIAL MEMBRANE;

EID: 0032752779     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.5.431     Document Type: Article

References (62)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-range implications in tissue knetics. Br J Cancer 1972;26:239-57.
2. Martin SJ, Green D. Protease activation during apoptosis: death by a thousand cuts? Cell 1995;28:349-52.
3. Citron BA, Zhang SX, Smirnova IV, Festroff BW. Apoptotic, injury-induced cell death in cultured mouse murine motor neurons. Neurosci Lett 1997;230:25-8.
4. Vaishnaw AK, McNally J, Elkon KB. Apoptosis in the rheumatic diseases. Arthritis Rheum 1997;40:1917-27.
5. 3 H-thymidine incorporating cells in rheumatoid arthritis synovial membrane. Rheumatol Int 1986;6:269-71.
6. Konttinen YT, Nykänen P, Nordström D, Saari H, Sandelin J, Santavirta S et al. DNA synthesis in prolyl 4-hydroxylase positive fibroblasts in situ in synovial tissue. An autoradiography-immunoperoxidase double labeling study. J Rheumatol 1989;16:339-45.
7. Fassbender H-G. Inflammatory reactions in arthritis. In: Davies ME, Dingle JT, eds. Immunopharmacology of joints and connective tissue. London: Academic Press, 1994:166-98.
8. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
9. Firestein GS, Yelo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synoviocytes. J Clin Invest 1995;96:1631-8.
10. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995;38:485-91.
11. Sugiyama M, Tsukazaki T, Yonekura A, Matsuzuki S, Yamashita S, Iwasaki K. Localization of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 1996;55:442-9.
12. Matsumoto S, Müller-Ladner U, Gay RE, Nishioka K, Gay S. Ultrastructural demonstration of apoptosis, Fas and bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 1996;23:1345-52.
13. Hoa TTM, Hasunuma T, Aono H, Masuko K, Kobata T, Yamamoto K et al. Novel mechanism of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J Rheumatol 1996;23:1332-7.
14. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Aoyagi T et al. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor β1. Arthritis Rheum 1996;39:1267-76.
15. Hasunuma T, Kayagaki N, Asahara H, Motokawa S, Kobata T, Yagita H et al. Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 1997;40:80-6.
16. Cantwell MJ, Hua T, Zvaifler N, Kipps T. Deficient Fas ligand expression by synovial lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 1997;40: 1644-52.
17. Kingsley G, Panayi G. Antigenic responses in reactive arthritis. Rheum Dis Clin North Am 1992;18:49-66.
18. Troughton PR, Morgan AW. Laboratory findings and pathology of psoriatic arthritis. Baillière's Clin Rheumatol 1994;8:439-63.
19. Panayi GS. Immunology of psoriasis and psoriatic arthritis. Baillière's Clin Rheumatol 1994;8:419-27.
20. Konttinen YT, Reitamo S, Ranki A, Häyry P, Kankaanpää U, Wegelius O. Characterization of the immunocompetent cells of rheumatoid synovium from tissue sections and eluates. Arthritis Rheum 1981;24:71-9.
21. Konttinen YT, Bergroth V, Nordström D, Koota K, Skriftvars B, Hagman G et al. Cellular immunohistopathology of acute, subacute and chronic synovitis in rheumatoid arthritis. Ann Rheum Dis 1985;44:549-55.
22. Hermann E. T cells in reactive arthritis. APMIS 1993; 10:177-86.
23. Lindblad S, Klareskog L, Hedfors E, Forsum U, Sundström CH. Phenotypic characterization of synovial tissue cells in situ in different types of synovitis. Arthritis Rheum 1983;26:1321-32.
24. Smith MD, O'Donnell J, Highton J, Palmer DG, Rozenbilds M, Roberts-Thomson PJ. Immunohistochemical analysis of synovial membranes from inflammatory and non-inflammatory arthritides: scarcity of CD5 positive B cells and IL-2. Pathology 1992;24:19-26.
25. Čeponis A, Konttinen YT, Imai S, Tamulaitiene M, Li TF, Xu J-W et al. Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: a comparative quantitative morphometric study. Br J Rheumatol 1998;37:170-8.
26. Roivainen A, Isomäki P, Nikkari S, Saario R, Vuori K, Toivanen P. Oncogene expression in synovial fluid cells in reactive and early rheumatoid arthritis: a brief report. Br J Rheumatol 1995;34:805-8.
27. Roivainen A, Söderström KO, Pirilä L, Aro H, Kortekangas P, Merilahti-Palo R et al. Oncoprotein expression in human synovial tissue: an immunohistochemical study of different types of arthritis. Br J Rheumatol 1996;35:933-42.
28. Roivainen A, Jalava J, Pirilä L, Yli-Jama T, Tiusanen H, Toivanen P. H-ras oncogene point mutations in arthritic synovium. Arthritis Rheum 1997;40:16-43.
29. Isomäki P, Söderström KO, Punnonen J, Roivainen A, Luukkainen R, Merilahti-Palo R et al. Expression of bcl-2 in rheumatoid arthritis. Br J Rheumatol 1996;35:611-9.
30. Zdichavsky M, Schropp C, Nickels A, Koch B, Pfreudschuh M, Gause A. Analysis of bcl-2+ lymphocyte subpopulations in inflammed synovial infiltrates by a double-immunostaining technique. Rheumatol Int 1996; 16:151-7.
31. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1998;31:315-24.
32. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29:1039-49.
33. Wilkinson DG (ed.) In situ hybridization: A practical approach. Oxford: IRL Press, 1992:75-83.
34. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
35. Siegel S, Castellan NJ Jr. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill, 1988: 156-61.
36. Henderson B, Revell PA, Edwards JC. Synovial lining cell hyperplasia in rheumatoid arthritis: dogma and fact. Ann Rheum Dis 1988;47:348-9.
37. Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, FitzGerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993;36:893-900.
38. Pompelano M, Hvala M, Chun J. Onset of apoptotic DNA fragmentation can precede cell elimination by days in the small intestinal villus. Cell Death Differ 1998; 5:702-9.
39. Konttinen YT, Nordström D, Bergroth V, Leirisalo-Repo M, Skrifvars B. Cell-mediated immune response in the diseased joints in patients with reactive arthritis. Scand J Immunol 1986;23:685-91.
40. Nordström D, Konttinen YT. Reactive arthritis - an update. Biomed Pharmacother 1989;43:737-42.
41. Lauhio A, Sorsa T, Lindy O, Suomalainen K, Saari H, Golub LM et al. The anti-inflammatory potential of lymecycline in long-term treatment of reactive arthritis. Arthritis Rheum 1992;35:195-8.
42. Lauhio A, Sorsa T, Lindy O, Suomalainen K, Saari H, Golub LM et al. The regulatory role of doxycycline/ tetracycline in collagenolytic activity and tissue destruction in joint diseases. Arthritis Rheum 1993;36:1335-6.
43. Østensen M, Førre O. Modulation of human natural killer cell function by cytokines and rheumatic disease. Scand J Rheumatol 1998;76(suppl.):183-8.
44. Matsuoka N, Eguchi K, Kawakami A, Ida H, Nakashima M, Sakai M et al. Phenotypic characteristics of T cells interacted with synovial cells. J Rheumatol 1991;18:1137-42.
45. Griffiths MG, Alpert S, Lambert E, McGuire J, Weissman IL. Perform and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc Natl Acad Sci USA 1992;89:549-53.
46. Nordström DC, Konttinen YT, Sorsa T, Nykänen P, Pettersson T, Santavirta S et al. Granzyme A-immunoreactive cells in synovial fluid in reactive and rheumatoid arthritis. Clin Rheumatol 1992;11:529-32.
47. Tak PP, Kummer A, Hack CE, Daha MR, Smeets TJM, Erkelens GW et al. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum 1994;37:1735-43.
48. Smith MD, Roberts-Thomson PJ. Interleukin 2 and interleukin 2 inhibitors in human serum and synovial fluid. II. Mitogenic stimulation, interleukin 2 production and interleukin 2 receptor expression in rheumatoid arthritis, psoriatic arthritis and Reiter's syndrome. J Rheumatol 1989;16:897-903.
49. Kotake S, Schumacher HR Jr, Yarboro CH, Arayssi TK, Pando JA, Kanik KS et al. In vivo gene expression of type 1 and type 2 cytokines in synovial tissue from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis. Proc Assoc Am Phys 1997;109:286-301.
50. Kanik KS, Hagiwara E, Yarboro CH, Schumacher HR, Wilder RL, Klinman DM. Distinct pattern of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. J Rheumatol 1998;25:16-22.
51. Berke G. Killing mechanism of cytotoxic lymphocytes. Curr Opin Hematol 1997;4:32-40.
52. Blake DR, Merry P, Unsworth J, Kidd BL, Outhwaite JM, Ballard R et al. Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1989;i:289-93.
53. Levick JR. Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure. J Rheumatol 1990;17:579-82.
54. Čeponis A, Konttinen YT, Mackevičius Z, Solovieva SA, Hukkanen M, Tamulaitienė M et al. Aberrant vascularity and von Willebrand factor distribution in inflamed synovial membrane. J Rheumatol 1996;23:1880-6.
55. Schroter M, Lowin B, Borner C, Tschopp J. Regulation of Fas (Apo-1/CD95) and perforine mediated lytic pathway of primary cytotoxic T lymphocytes by the protooncogene bcl-2. Eur J Immunol 1995;25:3509-13.
56. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-7.
57. McQueen FM, Skinner MA, Krissansen GW, Robinson E, Tan PL. Natural killer cell function and expression of beta 7 integrin in psoriatic arthritis. J Rheumatol 1994;21:2266-73.
58. Ruggeri R, Pulsatelli L, Melchiorri C, Da Re R, Focherini MC, Veronesi M et al. Differential expression of IL-1 and TNF receptors in inflammatory arthritis and osteoarthritis. Boll Soc Ital Biol Sper 1996;72:15-20.
59. Konttinen YT, Bluestein HG, Zvaifler NJ. Regulation of the growth of Epstein-Barr virus infected B cells. I. Growth regression by E-rosetting cells from VGA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8 memory cells. J Immunol 1985;134:2287-93.
60. Konttinen YT, Bluestein HG, Zvaifler NJ. Regulation of the growth of Epstein-Barr virus infected B cells: Temporal profile of the in vitro development of three distinct cytotoxic cells. Cell Immunol 1986;103:84-95.
61. Susskind B, Shornick MD, Iannotti MR, Duffy B, Mehrotra PT, Siegel JP et al. Cytolytic effector mechanisms of human CD4+ cytotoxic T lymphocytes. Hum Immunol 1996;45:64-75.
62. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996;149:2143-51.